Analysis of Drug Impurities

Richard J. Smith & Michael L. Webb

Blackwell Publishing
Logo

Spine
Analysis of Drug Impurities Smith & Webb Logo

Back Cover
Analysis of Drug Impurities
Richard J. Smith & Michael L. Webb

A key component of the overall quality of a pharmaceutical is control of impurities, as their presence, even in small amounts, may affect drug safety and efficacy. The identification and quantification of impurities to acceptable standards presents a significant challenge to the analytical chemist. Analytical science is developing rapidly and provides increasing opportunity to identify the structure, and therefore the origin and safety implications of these impurities, and the challenges of their measurement drives the development of modern quantitative methods.

Written for both practicing and student analytical chemists, Analysis of Drug Impurities provides a detailed overview of the challenges and the techniques available to permit accurate identification and quantification of drug impurities.

Richard Smith is Director, Analytical Sciences at GlaxoSmithKline Research and Development, Tonbridge, UK and Michael Webb is Director, Analytical Sciences at GlaxoSmithKline Research and Development, Stevenage, UK.

Also available from Blackwell Publishing

Pharmaceutical Analysis
Edited by David C. Lee and Michael L. Webb
Hardback (978 1841 27335 8), 384 pages

Preparative Enantioselective Chromatography
Edited by Geoffrey B. Cox,
Hardback (978 14051 1870 5), 344 pages

Process Analytical Technology
Edited by Katherine A. Bakeev,
Hardback, (978 14051 2103 3), 466 pages

Inductively Coupled Plasma Spectrometry and its Applications
2nd Edition
Edited by Steve J. Hill
Hardback, (978 1405 13594 8), 448 pages